Asset Details
Do you wish to reserve the book?
Acetylation modification regulates GRP78 secretion in colon cancer cells
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Acetylation modification regulates GRP78 secretion in colon cancer cells
Do you wish to request the book?
Acetylation modification regulates GRP78 secretion in colon cancer cells
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Acetylation modification regulates GRP78 secretion in colon cancer cells
2016
Overview
High glucose-regulated protein 78 (GRP78) expression contributes to the acquisition of a wide range of phenotypic cancer hallmarks and the pleiotropic oncogenic functions of GRP78 may result from its diverse subcellular distribution. Interestingly, GRP78 has been reported to be secreted from solid tumour cells, participating in cell-cell communication in the tumour microenvironment. However, the mechanism underlying this secretion remains elusive. Here, we report that GRP78 is secreted from colon cancer cells via exosomes. Histone deacetylase (HDAC) inhibitors blocked GRP78 release by inducing its aggregation in the ER. Mechanistically, HDAC inhibitor treatment suppressed HDAC6 activity and led to increased GRP78 acetylation; acetylated GRP78 then bound to VPS34, a class III phosphoinositide-3 kinase, consequently preventing the sorting of GRP78 into multivesicular bodies (MVBs). Of note, we found that mimicking GRP78 acetylation by substituting the lysine at residue 633, one of the deacetylated sites of HDAC6, with a glutamine resulted in decreased GRP78 secretion and impaired tumour cell growth
in vitro
. Our study thus reveals a hitherto-unknown mechanism of GRP78 secretion and may also provide implications for the therapeutic use of HDAC inhibitors.
Publisher
Nature Publishing Group UK,Nature Publishing Group
Subject
/ 13/106
/ 13/109
/ 13/95
/ 14/19
/ 38
/ 38/90
/ 64
/ 64/60
/ Animals
/ Class III Phosphatidylinositol 3-Kinases - metabolism
/ Colonic Neoplasms - metabolism
/ Endoplasmic Reticulum - metabolism
/ Female
/ Heat-Shock Proteins - secretion
/ Histone Deacetylase 6 - antagonists & inhibitors
/ Histone Deacetylase Inhibitors - pharmacology
/ Humanities and Social Sciences
/ Humans
/ Mice
/ Protein Processing, Post-Translational
/ Science
